TTNP
Titan Pharmaceuticals, Inc.
OTCQB
Contact Info
- 400 Oyster Point Blvd.
- Suite 505
- South San Francisco, CA 94080
- Website: http://www.titanpharm.com
- Phone: 650-244-4990
- Email: investors@titanpharm.com
Update Company Info
Business Description
Titan Pharmaceuticals, Inc is a biopharmaceutical company focused in the development of products for the treatment of central nervous system (CNS) diseases.
Financial Reporting/Disclosure
| Reporting Status | U.S. Reporting: SEC Filer |
| Audited Financials | Not Available |
| Latest Report | Not Available |
| Regulatory Agency | Not Available |
| CIK | 0000910267 |
| Fiscal Year End | 12/31 |
| OTC Market Tier | OTCQB |
Profile Data
| SIC - Industry Classification | 2836 - Biological products, except diagnostic |
| Incorporated In: | DE, USA |
| Year of Inc. | Not Available |
| Employees | Not Available |
Company Officers
| Sunil Bhonsle | President, Secretary |
| Robert E. Farrell | EVP, CFO |
| Brain Crowley | VP, Fin. |
Company Directors
| Marc Rubin | Executive Chairman |
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
TTNP Security Details
Share Structure
| Market Value1 | $48,880,157 | a/o May 24, 2012 |
| Shares Outstanding | 66,054,266 | a/o May 08, 2012 |
| Float | Not Available | |
| Authorized Shares | Not Available | |
| Par Value | 0.001 |
Shareholders
| Shareholders of Record | 142 | a/o Mar 23, 2012 |
Short Selling Data
| Short Interest | 606,601 (-0.83%) May 15, 2012 |
| Significant Failures to Deliver | No |
Transfer Agent(s)
| Continental Stock Transfer & Trust Company |
1Market Value calculated only for respective security
